Literature DB >> 8702588

Role of oxoproline in the regulation of neutral amino acid transport across the blood-brain barrier.

W J Lee1, R A Hawkins, D R Peterson, J R Viña.   

Abstract

Regulation of neutral amino acid transport was studied using isolated plasma membrane vesicles derived from the bovine blood-brain barrier. Neutral amino acids cross the blood-brain barrier by facilitative transport system L1, which may allow both desirable and undesirable amino acids to enter the brain. The sodium-dependent amino acid systems A and Bo,+ are located exclusively on abluminal membranes, in a position to pump unwanted amino acids out. gamma-Glutamyl transpeptidase, the first enzyme of the gamma-glutamyl cycle, is an integral protein of the luminal membrane of the blood-brain barrier. We demonstrate that oxoproline, an intracellular product of the gamma-glutamyl cycle, stimulates the sodium-dependent systems A and Bo,+ by 70 and 20%, respectively. Study of system A showed that 2 mM oxoproline increased the affinity for its specific substrate N-methylaminoisobutyrate by 50%. This relationship between the activity of the gamma-glutamyl cycle and system A transport may provide a short term regulatory mechanism by which the entry of potentially deleterious amino acids (i.e. neurotransmitters or their precursors) may be retarded and their removal from brain accelerated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702588     DOI: 10.1074/jbc.271.32.19129

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Authors:  Shotaro Sasaki; Yuya Futagi; Masaki Kobayashi; Jiro Ogura; Ken Iseki
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

2.  Metabolome-based signature of disease pathology in MS.

Authors:  S L Andersen; F B S Briggs; J H Winnike; Y Natanzon; S Maichle; K J Knagge; L K Newby; S G Gregory
Journal:  Mult Scler Relat Disord       Date:  2019-03-09       Impact factor: 4.339

3.  Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.

Authors:  Jacques Viljoen; Jakobus J Bergh; Lodewyk J Mienie; Hercullas F Kotze; Gisella Terre'Blanche
Journal:  Metab Brain Dis       Date:  2012-02-17       Impact factor: 3.584

4.  Interpretation of plasma amino acids in the follow-up of patients: the impact of compartmentation.

Authors:  Claude Bachmann
Journal:  J Inherit Metab Dis       Date:  2008-01-31       Impact factor: 4.982

5.  A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats.

Authors:  B Alexander; X Li; I S Benjamin; M B Segal; R Sherwood; J E Preston
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.655

6.  Escherichia coli, an Intestinal Microorganism, as a Biosensor for Quantification of Amino Acid Bioavailability.

Authors:  Vesela I Chalova; Sujata A Sirsat; Corliss A O'Bryan; Philip G Crandall; Steven C Ricke
Journal:  Sensors (Basel)       Date:  2009-09-04       Impact factor: 3.576

Review 7.  How Glutamate Is Managed by the Blood-Brain Barrier.

Authors:  Richard A Hawkins; Juan R Viña
Journal:  Biology (Basel)       Date:  2016-10-08

8.  Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Austin L Brown; Pagna Sok; Olga Taylor; John P Woodhouse; M Brooke Bernhardt; Kimberly P Raghubar; Lisa S Kahalley; Philip J Lupo; Marilyn J Hockenberry; Michael E Scheurer
Journal:  J Pain Symptom Manage       Date:  2020-09-01       Impact factor: 3.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.